MRK Merck & Co., Inc.
$148.78
Merck & Co., Inc. (MRK) is expected to report earnings on October 29, 2026, before the market open. The consensus earnings estimate is $2.25 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +15.8% since its last earnings release on August 4, 2026.
Merck & Co. Beat Expectations, Guides In-line
Tuesday, August 4, 2026 · 6:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 29
Thursday · 6:30 AM ET
Earnings Whisper
-
vs $2.25
Rev est $17.61B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$145.05
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Merck & Co., Inc.
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products.
Sector
Healthcare
Industry
Drug Manufacturers / Major
Held By 15 ETFs, by dollar flow
- OEF iShares S&P 100 ETF
- OEF iShares S&P 100 ETF
- XLG Invesco S&P 500 Top 50 ETF
- XT iShares Exponential Technologies ETF
- XT iShares Exponential Technologies ETF
- XLG Invesco S&P 500 Top 50 ETF
- IOO iShares Global 100 ETF
- IOO iShares Global 100 ETF
- DIA SPDR Dow Jones Industrial Average ETF
- DIA SPDR Dow Jones Industrial Average ETF
- DVY iShares Select Dividend ETF
- DVY iShares Select Dividend ETF
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
Charts powered in part by Lightweight Charts™ by TradingView.